Bender Robert & Associates Eli Lilly & CO Transaction History

Bender Robert & Associates

$455 Million
Q2 2024

A detailed history of Bender Robert & Associates transactions in Eli Lilly & CO stock. As of the latest transaction made, Bender Robert & Associates holds 18,209 shares of LLY stock, worth $16.2 Million. This represents 3.62% of its overall portfolio holdings.

Number of Shares

18,209

Previous 19,426 6.26%

Holding current value

$16.2 Million

Previous $15.1 Million 9.09%

% of portfolio

3.62%

Previous 3.54%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$592.2 - $792.28 $229,181 - $306,612	-387 Reduced 1.95%	19,426 $15.1 Million
Q4 2023 Jan 31, 2024	BUY	$525.19 - $619.13 $11,554 - $13,620	22 Added 0.11%	19,813 $11.5 Million
Q3 2023 Oct 13, 2023	BUY	$434.7 - $599.3 $13,041 - $17,979	30 Added 0.15%	19,791 $10.6 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $3.02 Million - $4.04 Million	8,611 Added 77.23%	19,761 $9.27 Million
Q1 2023 Apr 20, 2023	BUY	$310.63 - $364.82 $36,033 - $42,319	116 Added 1.05%	11,150 $3.83 Million
Q4 2022 Feb 02, 2023	BUY	$321.55 - $374.67 $24,116 - $28,100	75 Added 0.68%	11,034 $4.04 Million
Q3 2022 Oct 26, 2022	BUY	$296.48 - $337.87 $219,395 - $250,023	740 Added 7.24%	10,959 $3.54 Million
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $54,352 - $63,817	195 Added 1.95%	10,219 $3.31 Million
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $229,996 - $285,826	980 Added 10.84%	10,024 $2.87 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $1.06 Million - $1.3 Million	4,783 Added 112.25%	9,044 $2.09 Million
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $1.06 Million - $1.3 Million	-4,778 Reduced 52.86%	4,261 $697,000
Q2 2021 Jul 16, 2021	BUY	$180.55 - $233.54 $171,883 - $222,330	952 Added 11.77%	9,039 $2.08 Million
Q1 2021 Apr 28, 2021	BUY	$164.32 - $212.72 $121,103 - $156,774	737 Added 10.03%	8,087 $1.51 Million
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $111,543 - $147,598	855 Added 13.16%	7,350 $1.24 Million
Q3 2020 Oct 29, 2020	BUY	$146.22 - $169.13 $29,244 - $33,826	200 Added 3.18%	6,495 $961,000
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $114,592 - $137,911	840 Added 15.4%	6,295 $1.03 Million
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $12,081 - $14,964	-113 Reduced 2.03%	5,455 $717,000
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $13,848 - $16,165	-125 Reduced 2.2%	5,568 $603,000
Q1 2019 Apr 30, 2019	BUY	$111.31 - $131.02 $13,913 - $16,377	125 Added 2.24%	5,693 $739,000
Q4 2018 Jan 24, 2019	BUY	$105.9 - $118.64 $2,647 - $2,966	25 Added 0.45%	5,568 $644,000
Q3 2018 Oct 17, 2018	SELL	$85.86 - $107.31 $13,737 - $17,169	-160 Reduced 2.81%	5,543 $595,000
Q2 2018 Jul 27, 2018	SELL	$75.7 - $86.88 $8,327 - $9,556	-110 Reduced 1.89%	5,703 $487,000
Q1 2018 Apr 27, 2018	SELL	$74.21 - $87.6 $8,163 - $9,636	-110 Reduced 1.86%	5,813 $450,000
Q4 2017 Jan 19, 2018	SELL	$81.94 - $87.89 $11,471 - $12,304	-140 Reduced 2.31%	5,923 $500,000
Q3 2017 Oct 23, 2017	BUY	$77.07 - $85.54 $467,275 - $518,629	6,063	6,063 $519,000

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.

Account

Bender Robert & Associates Eli Lilly & CO Transaction History